Phase 2a clinical trials
Scope
Date
~
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Energy
LS Cable inks $159 mn Taiwan submarine cable supply contract
LS Cable & System Ltd., South Korea’s top wire and cable producer, signed a formal contract worth 150 million euros ($159 million) to supp...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Healthcare
KT adds partner to expand Vietnam digital healthcare biz
KT Corp., a major South Korean telecom operator, has teamed up with another local company to expand its digital healthcare business in Vietnam furth...
Nov 07, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio suffers as weak won lifts global clinical trial costs
South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...
Oct 14, 2022 (Gmt+09:00)
-
Batteries
POSCO Holdings to invest extra $1.1 billion in Argentine lithium plant
POSCO Group, which owns South Korea’s largest steelmaker, plans to invest an additional $1.09 billion, or 5 trillion won, in its lithium produ...
Oct 11, 2022 (Gmt+09:00)
-
Healthcare
Precision to supply to Antech for US vet diagnostics market entry
A number of veterinary diagnostics companies are struggling to differentiate themselves in the global market. According to Grand View Research Inc.,...
Jul 05, 2022 (Gmt+09:00)
-
Bio & Pharma
KT, Hanmi-invested therapeutics maker Digital Pharm launched
Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...
Jun 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...
Jun 14, 2022 (Gmt+09:00)
language -
Pre-IPOs
Lemon Healthcare aims for IPO and triple jump in revenue
Imagine making a doctor’s appointment with a click of a button on a smartphone app. Once at the clinic or hospital, the app will guide the use...
Jun 02, 2022 (Gmt+09:00)
-
Robotics
Hyundai Robotics, Vodafone to provide service robots in Germany
South Korean robotics firm Hyundai Robotics Co. announced it signed a letter of intent for a business partnership with global telecommunications gia...
May 31, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
-
Energy
Suresofttech wins deal to verify NuScale’s mini reactor software
Suresofttech Co., a South Korean developer of verification tools for software quality, has won a deal to check a key system in small-size reactors m...
Mar 11, 2022 (Gmt+09:00)
-
Metaverse
Biotech firm EDGC embarks on metaverse journey
EONE-DIAGNOMICS Genome Center Co. ( EDGC ) announced this week it would participate in AI Human Metaverse Project consortium – along with seven ...
Jan 05, 2022 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Electronics
LG to expand medical equipment business with pain-relieving device
LG Electronics Inc. is expanding its business scope to the medical equipment sector with a plan to unveil a pain-relieving device in an effort to ga...
Nov 10, 2021 (Gmt+09:00)
language -
Banking & Finance
Citibank Korea to shut down retail business in phases
Citibank Korea has decided to close its consumer banking operations in phases, the bank said on Monday, after its attempt to find a buyer of the bus...
Oct 25, 2021 (Gmt+09:00)
-
Food & Beverage
Food triggers next phase of global K-culture craze
The ongoing global fever over South Korean music and entertainment content is driving the rapid growth of the country’s packaged food manufact...
Oct 05, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience to kick off phase 3 vaccine trials
SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...
Aug 10, 2021 (Gmt+09:00)
language -
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
Artificial intelligence
Samsung SDS showcases new supply chain management solution in the US
Samsung SDS introduced a supplier relationship management (SRM) solution at the Gartner Supply Chain Symposium 2024 in Orlando, Florida, the com...
1 MINUTES AGO